nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A16—Doxorubicin—muscle cancer	0.533	0.666	CbGbCtD
L-Carnitine—SLC22A5—Dactinomycin—muscle cancer	0.107	0.134	CbGbCtD
L-Carnitine—XDH—Doxorubicin—muscle cancer	0.0919	0.115	CbGbCtD
L-Carnitine—SLCO1B1—Methotrexate—muscle cancer	0.0354	0.0443	CbGbCtD
L-Carnitine—SLC22A8—Methotrexate—muscle cancer	0.0327	0.0409	CbGbCtD
L-Carnitine—XDH—Effects of Nitric Oxide—MB—muscle cancer	0.0109	0.318	CbGpPWpGaD
L-Carnitine—CES1—larynx—muscle cancer	0.0082	0.0663	CbGeAlD
L-Carnitine—CROT—Vinorelbine—Vincristine—muscle cancer	0.00672	1	CbGdCrCtD
L-Carnitine—SLC22A4—larynx—muscle cancer	0.00625	0.0506	CbGeAlD
L-Carnitine—SLC22A16—renal system—muscle cancer	0.00492	0.0398	CbGeAlD
L-Carnitine—SLC22A16—bone marrow—muscle cancer	0.00372	0.0301	CbGeAlD
L-Carnitine—CROT—smooth muscle tissue—muscle cancer	0.0037	0.0299	CbGeAlD
L-Carnitine—SLC22A16—testis—muscle cancer	0.00318	0.0257	CbGeAlD
L-Carnitine—CRAT—smooth muscle tissue—muscle cancer	0.00312	0.0252	CbGeAlD
L-Carnitine—SLC25A20—renal system—muscle cancer	0.0031	0.025	CbGeAlD
L-Carnitine—CRAT—renal system—muscle cancer	0.003	0.0243	CbGeAlD
L-Carnitine—CROT—tendon—muscle cancer	0.00278	0.0225	CbGeAlD
L-Carnitine—SLC25A20—cardiac atrium—muscle cancer	0.00277	0.0224	CbGeAlD
L-Carnitine—CROT—bone marrow—muscle cancer	0.00269	0.0218	CbGeAlD
L-Carnitine—CRAT—cardiac atrium—muscle cancer	0.00269	0.0218	CbGeAlD
L-Carnitine—SLC25A29—head—muscle cancer	0.0026	0.021	CbGeAlD
L-Carnitine—CROT—vagina—muscle cancer	0.00258	0.0209	CbGeAlD
L-Carnitine—SLC25A29—testis—muscle cancer	0.00251	0.0203	CbGeAlD
L-Carnitine—CPT1A—renal system—muscle cancer	0.00243	0.0197	CbGeAlD
L-Carnitine—SLC25A20—tendon—muscle cancer	0.00242	0.0196	CbGeAlD
L-Carnitine—CROT—head—muscle cancer	0.00238	0.0193	CbGeAlD
L-Carnitine—CRAT—tendon—muscle cancer	0.00234	0.019	CbGeAlD
L-Carnitine—SLC25A20—bone marrow—muscle cancer	0.00234	0.0189	CbGeAlD
L-Carnitine—CPT2—renal system—muscle cancer	0.00231	0.0187	CbGeAlD
L-Carnitine—CROT—testis—muscle cancer	0.0023	0.0186	CbGeAlD
L-Carnitine—CRAT—bone marrow—muscle cancer	0.00227	0.0184	CbGeAlD
L-Carnitine—SLC25A20—vagina—muscle cancer	0.00224	0.0181	CbGeAlD
L-Carnitine—CRAT—vagina—muscle cancer	0.00218	0.0176	CbGeAlD
L-Carnitine—SLC25A20—head—muscle cancer	0.00207	0.0168	CbGeAlD
L-Carnitine—MPO—C-MYB transcription factor network—MYF6—muscle cancer	0.00207	0.0606	CbGpPWpGaD
L-Carnitine—CPT2—cardiac atrium—muscle cancer	0.00207	0.0167	CbGeAlD
L-Carnitine—CRAT—head—muscle cancer	0.00201	0.0163	CbGeAlD
L-Carnitine—SLC25A20—testis—muscle cancer	0.002	0.0162	CbGeAlD
L-Carnitine—CRAT—testis—muscle cancer	0.00194	0.0157	CbGeAlD
L-Carnitine—CPT1A—tendon—muscle cancer	0.0019	0.0154	CbGeAlD
L-Carnitine—CPT2—tendon—muscle cancer	0.0018	0.0146	CbGeAlD
L-Carnitine—CES1—E2F transcription factor network—TFE3—muscle cancer	0.0018	0.0527	CbGpPWpGaD
L-Carnitine—XDH—renal system—muscle cancer	0.0018	0.0146	CbGeAlD
L-Carnitine—CPT1A—vagina—muscle cancer	0.00176	0.0143	CbGeAlD
L-Carnitine—CPT2—bone marrow—muscle cancer	0.00175	0.0141	CbGeAlD
L-Carnitine—CPT2—vagina—muscle cancer	0.00167	0.0135	CbGeAlD
L-Carnitine—CPT1A—head—muscle cancer	0.00163	0.0132	CbGeAlD
L-Carnitine—CPT1A—testis—muscle cancer	0.00157	0.0127	CbGeAlD
L-Carnitine—CPT2—head—muscle cancer	0.00155	0.0125	CbGeAlD
L-Carnitine—CPT2—testis—muscle cancer	0.00149	0.0121	CbGeAlD
L-Carnitine—XDH—vagina—muscle cancer	0.0013	0.0105	CbGeAlD
L-Carnitine—CES1—E2F transcription factor network—TP73—muscle cancer	0.00122	0.0356	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	0.00121	0.0354	CbGpPWpGaD
L-Carnitine—SLCO1B1—renal system—muscle cancer	0.00118	0.00954	CbGeAlD
L-Carnitine—CPT2—PPARA activates gene expression—MED12—muscle cancer	0.00116	0.0338	CbGpPWpGaD
L-Carnitine—MPO—renal system—muscle cancer	0.00115	0.00927	CbGeAlD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	0.00113	0.0331	CbGpPWpGaD
L-Carnitine—Abdominal cramps—Vincristine—muscle cancer	0.0011	0.0305	CcSEcCtD
L-Carnitine—SLC22A4—renal system—muscle cancer	0.00105	0.00847	CbGeAlD
L-Carnitine—CES1—head—muscle cancer	0.000918	0.00743	CbGeAlD
L-Carnitine—SLC22A8—renal system—muscle cancer	0.000916	0.00741	CbGeAlD
L-Carnitine—CES1—testis—muscle cancer	0.000887	0.00718	CbGeAlD
L-Carnitine—MPO—bone marrow—muscle cancer	0.000866	0.00701	CbGeAlD
L-Carnitine—MPO—C-MYB transcription factor network—MYOD1—muscle cancer	0.000824	0.0241	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CD34—muscle cancer	0.000824	0.0241	CbGpPWpGaD
L-Carnitine—SLC22A4—tendon—muscle cancer	0.000817	0.00661	CbGeAlD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TP73—muscle cancer	0.000813	0.0238	CbGpPWpGaD
L-Carnitine—CPT1A—PPARA activates gene expression—MED12—muscle cancer	0.000801	0.0234	CbGpPWpGaD
L-Carnitine—SLC22A4—bone marrow—muscle cancer	0.000791	0.0064	CbGeAlD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	0.000784	0.0229	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	0.00078	0.0228	CbGpPWpGaD
L-Carnitine—MPO—head—muscle cancer	0.000767	0.0062	CbGeAlD
L-Carnitine—SLC22A4—vagina—muscle cancer	0.000758	0.00613	CbGeAlD
L-Carnitine—MPO—testis—muscle cancer	0.000741	0.00599	CbGeAlD
L-Carnitine—SLC22A5—renal system—muscle cancer	0.000692	0.0056	CbGeAlD
L-Carnitine—Cardiovascular disorder—Etoposide—muscle cancer	0.000685	0.019	CcSEcCtD
L-Carnitine—SLC22A5—cardiac atrium—muscle cancer	0.00062	0.00502	CbGeAlD
L-Carnitine—SLC22A8—head—muscle cancer	0.000613	0.00496	CbGeAlD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000567	0.0166	CbGpPWpGaD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	0.00054	0.0158	CbGpPWpGaD
L-Carnitine—SLC22A5—tendon—muscle cancer	0.00054	0.00437	CbGeAlD
L-Carnitine—SLC22A5—vagina—muscle cancer	0.000502	0.00406	CbGeAlD
L-Carnitine—Myasthenia—Doxorubicin—muscle cancer	0.000496	0.0138	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000482	0.0141	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000482	0.0141	CbGpPWpGaD
L-Carnitine—Muscular weakness—Vincristine—muscle cancer	0.000475	0.0132	CcSEcCtD
L-Carnitine—Hypercalcaemia—Doxorubicin—muscle cancer	0.000449	0.0125	CcSEcCtD
L-Carnitine—SLC22A5—testis—muscle cancer	0.000448	0.00362	CbGeAlD
L-Carnitine—CROT—Metabolism—FH—muscle cancer	0.000447	0.0131	CbGpPWpGaD
L-Carnitine—Weight decreased—Vincristine—muscle cancer	0.000421	0.0117	CcSEcCtD
L-Carnitine—Pharyngitis—Dactinomycin—muscle cancer	0.000414	0.0115	CcSEcCtD
L-Carnitine—Depression—Vincristine—muscle cancer	0.000414	0.0115	CcSEcCtD
L-Carnitine—Amblyopia—Doxorubicin—muscle cancer	0.000404	0.0112	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—FH—muscle cancer	0.00038	0.0111	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—FH—muscle cancer	0.00038	0.0111	CbGpPWpGaD
L-Carnitine—Cardiovascular disorder—Doxorubicin—muscle cancer	0.000355	0.00985	CcSEcCtD
L-Carnitine—Melaena—Methotrexate—muscle cancer	0.000352	0.00976	CcSEcCtD
L-Carnitine—Angiopathy—Vincristine—muscle cancer	0.000338	0.00939	CcSEcCtD
L-Carnitine—Anaemia—Dactinomycin—muscle cancer	0.000336	0.00932	CcSEcCtD
L-Carnitine—Renal failure—Etoposide—muscle cancer	0.000331	0.00918	CcSEcCtD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—muscle cancer	0.000324	0.00947	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—KIT—muscle cancer	0.000315	0.00922	CbGpPWpGaD
L-Carnitine—Back pain—Vincristine—muscle cancer	0.000314	0.00871	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000311	0.00908	CbGpPWpGaD
L-Carnitine—Injection site reaction—Doxorubicin—muscle cancer	0.00031	0.0086	CcSEcCtD
L-Carnitine—Myalgia—Dactinomycin—muscle cancer	0.000309	0.00858	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—CDKN2A—muscle cancer	0.000308	0.00901	CbGpPWpGaD
L-Carnitine—Hyperkalaemia—Doxorubicin—muscle cancer	0.000307	0.0085	CcSEcCtD
L-Carnitine—Melaena—Doxorubicin—muscle cancer	0.000305	0.00845	CcSEcCtD
L-Carnitine—Anaemia—Vincristine—muscle cancer	0.0003	0.00832	CcSEcCtD
L-Carnitine—Infection—Dactinomycin—muscle cancer	0.000295	0.00817	CcSEcCtD
L-Carnitine—Vertigo—Vincristine—muscle cancer	0.000292	0.00809	CcSEcCtD
L-Carnitine—Cramps of lower extremities—Doxorubicin—muscle cancer	0.000287	0.00795	CcSEcCtD
L-Carnitine—Anorexia—Dactinomycin—muscle cancer	0.000283	0.00784	CcSEcCtD
L-Carnitine—Eye disorder—Etoposide—muscle cancer	0.000282	0.00783	CcSEcCtD
L-Carnitine—Convulsion—Vincristine—muscle cancer	0.000281	0.0078	CcSEcCtD
L-Carnitine—Hypertension—Vincristine—muscle cancer	0.00028	0.00778	CcSEcCtD
L-Carnitine—Myalgia—Vincristine—muscle cancer	0.000276	0.00767	CcSEcCtD
L-Carnitine—Angiopathy—Etoposide—muscle cancer	0.000274	0.0076	CcSEcCtD
L-Carnitine—Hypertonia—Doxorubicin—muscle cancer	0.000273	0.00759	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00027	0.0075	CcSEcCtD
L-Carnitine—Infection—Vincristine—muscle cancer	0.000263	0.0073	CcSEcCtD
L-Carnitine—Decreased appetite—Dactinomycin—muscle cancer	0.000258	0.00715	CcSEcCtD
L-Carnitine—Dysgeusia—Etoposide—muscle cancer	0.000258	0.00714	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CDKN2A—muscle cancer	0.000256	0.00749	CbGpPWpGaD
L-Carnitine—Back pain—Etoposide—muscle cancer	0.000254	0.00706	CcSEcCtD
L-Carnitine—Pain—Dactinomycin—muscle cancer	0.000254	0.00704	CcSEcCtD
L-Carnitine—Muscle spasms—Etoposide—muscle cancer	0.000253	0.00701	CcSEcCtD
L-Carnitine—Anorexia—Vincristine—muscle cancer	0.000253	0.00701	CcSEcCtD
L-Carnitine—CROT—Metabolism—MED12—muscle cancer	0.000252	0.00738	CbGpPWpGaD
L-Carnitine—Hypotension—Vincristine—muscle cancer	0.000248	0.00687	CcSEcCtD
L-Carnitine—CPT2—Metabolism—FH—muscle cancer	0.000245	0.00716	CbGpPWpGaD
L-Carnitine—Anaemia—Etoposide—muscle cancer	0.000243	0.00674	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000242	0.00673	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000241	0.0067	CcSEcCtD
L-Carnitine—Insomnia—Vincristine—muscle cancer	0.00024	0.00665	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—PTGS2—muscle cancer	0.000239	0.007	CbGpPWpGaD
L-Carnitine—Paraesthesia—Vincristine—muscle cancer	0.000238	0.0066	CcSEcCtD
L-Carnitine—Vertigo—Etoposide—muscle cancer	0.000236	0.00655	CcSEcCtD
L-Carnitine—Abdominal pain—Dactinomycin—muscle cancer	0.000234	0.0065	CcSEcCtD
L-Carnitine—Body temperature increased—Dactinomycin—muscle cancer	0.000234	0.0065	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—PTGS2—muscle cancer	0.000231	0.00675	CbGpPWpGaD
L-Carnitine—Decreased appetite—Vincristine—muscle cancer	0.00023	0.00639	CcSEcCtD
L-Carnitine—CROT—Metabolism—ENO2—muscle cancer	0.00023	0.00673	CbGpPWpGaD
L-Carnitine—Cough—Etoposide—muscle cancer	0.000229	0.00637	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Vincristine—muscle cancer	0.000229	0.00635	CcSEcCtD
L-Carnitine—Convulsion—Etoposide—muscle cancer	0.000228	0.00632	CcSEcCtD
L-Carnitine—Hypertension—Etoposide—muscle cancer	0.000227	0.0063	CcSEcCtD
L-Carnitine—Constipation—Vincristine—muscle cancer	0.000227	0.00629	CcSEcCtD
L-Carnitine—Pain—Vincristine—muscle cancer	0.000227	0.00629	CcSEcCtD
L-Carnitine—Chest pain—Etoposide—muscle cancer	0.000224	0.00621	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—TP53—muscle cancer	0.00022	0.00644	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Dactinomycin—muscle cancer	0.000218	0.00606	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Vincristine—muscle cancer	0.000217	0.00601	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000215	0.0063	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—MED12—muscle cancer	0.000215	0.00628	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—MED12—muscle cancer	0.000215	0.00628	CbGpPWpGaD
L-Carnitine—Infection—Etoposide—muscle cancer	0.000213	0.00592	CcSEcCtD
L-Carnitine—Asthenia—Dactinomycin—muscle cancer	0.000213	0.0059	CcSEcCtD
L-Carnitine—Tachycardia—Etoposide—muscle cancer	0.000209	0.00581	CcSEcCtD
L-Carnitine—Body temperature increased—Vincristine—muscle cancer	0.000209	0.00581	CcSEcCtD
L-Carnitine—Abdominal pain—Vincristine—muscle cancer	0.000209	0.00581	CcSEcCtD
L-Carnitine—Anorexia—Etoposide—muscle cancer	0.000205	0.00568	CcSEcCtD
L-Carnitine—Diarrhoea—Dactinomycin—muscle cancer	0.000203	0.00563	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—PTGS2—muscle cancer	0.000202	0.0059	CbGpPWpGaD
L-Carnitine—Depression—Methotrexate—muscle cancer	0.000201	0.00558	CcSEcCtD
L-Carnitine—Hypotension—Etoposide—muscle cancer	0.000201	0.00556	CcSEcCtD
L-Carnitine—Gastritis—Doxorubicin—muscle cancer	0.0002	0.00556	CcSEcCtD
L-Carnitine—Muscular weakness—Doxorubicin—muscle cancer	0.0002	0.00554	CcSEcCtD
L-Carnitine—Renal failure—Methotrexate—muscle cancer	0.000198	0.0055	CcSEcCtD
L-Carnitine—Influenza—Doxorubicin—muscle cancer	0.000196	0.00543	CcSEcCtD
L-Carnitine—CRAT—Metabolism—ENO2—muscle cancer	0.000196	0.00572	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ENO2—muscle cancer	0.000196	0.00572	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Vincristine—muscle cancer	0.000195	0.00542	CcSEcCtD
L-Carnitine—Paraesthesia—Etoposide—muscle cancer	0.000193	0.00535	CcSEcCtD
L-Carnitine—Dyspnoea—Etoposide—muscle cancer	0.000191	0.00531	CcSEcCtD
L-Carnitine—Asthenia—Vincristine—muscle cancer	0.00019	0.00527	CcSEcCtD
L-Carnitine—Vomiting—Dactinomycin—muscle cancer	0.000189	0.00523	CcSEcCtD
L-Carnitine—Bronchitis—Doxorubicin—muscle cancer	0.000188	0.00522	CcSEcCtD
L-Carnitine—Rash—Dactinomycin—muscle cancer	0.000187	0.00519	CcSEcCtD
L-Carnitine—Decreased appetite—Etoposide—muscle cancer	0.000187	0.00518	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000185	0.00514	CcSEcCtD
L-Carnitine—Pain—Etoposide—muscle cancer	0.000184	0.00509	CcSEcCtD
L-Carnitine—Constipation—Etoposide—muscle cancer	0.000184	0.00509	CcSEcCtD
L-Carnitine—Haemoglobin—Methotrexate—muscle cancer	0.000182	0.00505	CcSEcCtD
L-Carnitine—Diarrhoea—Vincristine—muscle cancer	0.000181	0.00503	CcSEcCtD
L-Carnitine—Haemorrhage—Methotrexate—muscle cancer	0.000181	0.00502	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.00018	0.00527	CbGpPWpGaD
L-Carnitine—Pharyngitis—Methotrexate—muscle cancer	0.00018	0.00498	CcSEcCtD
L-Carnitine—Weight increased—Doxorubicin—muscle cancer	0.000178	0.00494	CcSEcCtD
L-Carnitine—Weight decreased—Doxorubicin—muscle cancer	0.000177	0.00491	CcSEcCtD
L-Carnitine—Nausea—Dactinomycin—muscle cancer	0.000176	0.00489	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Etoposide—muscle cancer	0.000175	0.00487	CcSEcCtD
L-Carnitine—Dizziness—Vincristine—muscle cancer	0.000175	0.00486	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—TP53—muscle cancer	0.000173	0.00505	CbGpPWpGaD
L-Carnitine—Renal failure—Doxorubicin—muscle cancer	0.000172	0.00476	CcSEcCtD
L-Carnitine—Body temperature increased—Etoposide—muscle cancer	0.00017	0.00471	CcSEcCtD
L-Carnitine—Abdominal pain—Etoposide—muscle cancer	0.00017	0.00471	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—FH—muscle cancer	0.00017	0.00496	CbGpPWpGaD
L-Carnitine—Urinary tract infection—Doxorubicin—muscle cancer	0.00017	0.00471	CcSEcCtD
L-Carnitine—Eye disorder—Methotrexate—muscle cancer	0.000169	0.00469	CcSEcCtD
L-Carnitine—Vomiting—Vincristine—muscle cancer	0.000168	0.00467	CcSEcCtD
L-Carnitine—Rash—Vincristine—muscle cancer	0.000167	0.00463	CcSEcCtD
L-Carnitine—Dermatitis—Vincristine—muscle cancer	0.000167	0.00463	CcSEcCtD
L-Carnitine—Headache—Vincristine—muscle cancer	0.000166	0.0046	CcSEcCtD
L-Carnitine—Angiopathy—Methotrexate—muscle cancer	0.000164	0.00455	CcSEcCtD
L-Carnitine—Sinusitis—Doxorubicin—muscle cancer	0.000164	0.00454	CcSEcCtD
L-Carnitine—Hypersensitivity—Etoposide—muscle cancer	0.000158	0.00439	CcSEcCtD
L-Carnitine—Haemoglobin—Doxorubicin—muscle cancer	0.000157	0.00437	CcSEcCtD
L-Carnitine—Nausea—Vincristine—muscle cancer	0.000157	0.00437	CcSEcCtD
L-Carnitine—Rhinitis—Doxorubicin—muscle cancer	0.000157	0.00436	CcSEcCtD
L-Carnitine—Haemorrhage—Doxorubicin—muscle cancer	0.000157	0.00435	CcSEcCtD
L-Carnitine—Pharyngitis—Doxorubicin—muscle cancer	0.000155	0.00431	CcSEcCtD
L-Carnitine—Oedema peripheral—Doxorubicin—muscle cancer	0.000154	0.00428	CcSEcCtD
L-Carnitine—Dysgeusia—Methotrexate—muscle cancer	0.000154	0.00428	CcSEcCtD
L-Carnitine—Asthenia—Etoposide—muscle cancer	0.000154	0.00427	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000153	0.00448	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000153	0.00448	CbGpPWpGaD
L-Carnitine—Back pain—Methotrexate—muscle cancer	0.000152	0.00423	CcSEcCtD
L-Carnitine—Pruritus—Etoposide—muscle cancer	0.000152	0.00421	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.000152	0.00443	CbGpPWpGaD
L-Carnitine—Diarrhoea—Etoposide—muscle cancer	0.000147	0.00407	CcSEcCtD
L-Carnitine—Eye disorder—Doxorubicin—muscle cancer	0.000146	0.00406	CcSEcCtD
L-Carnitine—Anaemia—Methotrexate—muscle cancer	0.000146	0.00404	CcSEcCtD
L-Carnitine—Angiopathy—Doxorubicin—muscle cancer	0.000142	0.00394	CcSEcCtD
L-Carnitine—Dizziness—Etoposide—muscle cancer	0.000142	0.00394	CcSEcCtD
L-Carnitine—Vertigo—Methotrexate—muscle cancer	0.000142	0.00393	CcSEcCtD
L-Carnitine—Arrhythmia—Doxorubicin—muscle cancer	0.00014	0.00388	CcSEcCtD
L-Carnitine—CPT2—Metabolism—MED12—muscle cancer	0.000138	0.00405	CbGpPWpGaD
L-Carnitine—Cough—Methotrexate—muscle cancer	0.000137	0.00381	CcSEcCtD
L-Carnitine—Convulsion—Methotrexate—muscle cancer	0.000136	0.00379	CcSEcCtD
L-Carnitine—Vomiting—Etoposide—muscle cancer	0.000136	0.00379	CcSEcCtD
L-Carnitine—Rash—Etoposide—muscle cancer	0.000135	0.00375	CcSEcCtD
L-Carnitine—Dermatitis—Etoposide—muscle cancer	0.000135	0.00375	CcSEcCtD
L-Carnitine—Headache—Etoposide—muscle cancer	0.000134	0.00373	CcSEcCtD
L-Carnitine—Myalgia—Methotrexate—muscle cancer	0.000134	0.00372	CcSEcCtD
L-Carnitine—Chest pain—Methotrexate—muscle cancer	0.000134	0.00372	CcSEcCtD
L-Carnitine—Dysgeusia—Doxorubicin—muscle cancer	0.000134	0.00371	CcSEcCtD
L-Carnitine—Back pain—Doxorubicin—muscle cancer	0.000132	0.00366	CcSEcCtD
L-Carnitine—Muscle spasms—Doxorubicin—muscle cancer	0.000131	0.00364	CcSEcCtD
L-Carnitine—Infection—Methotrexate—muscle cancer	0.000128	0.00354	CcSEcCtD
L-Carnitine—Nausea—Etoposide—muscle cancer	0.000127	0.00354	CcSEcCtD
L-Carnitine—CPT2—Metabolism—ENO2—muscle cancer	0.000126	0.00369	CbGpPWpGaD
L-Carnitine—Anaemia—Doxorubicin—muscle cancer	0.000126	0.0035	CcSEcCtD
L-Carnitine—Vertigo—Doxorubicin—muscle cancer	0.000123	0.0034	CcSEcCtD
L-Carnitine—Anorexia—Methotrexate—muscle cancer	0.000123	0.0034	CcSEcCtD
L-Carnitine—Palpitations—Doxorubicin—muscle cancer	0.000121	0.00334	CcSEcCtD
L-Carnitine—Hypotension—Methotrexate—muscle cancer	0.00012	0.00333	CcSEcCtD
L-Carnitine—Cough—Doxorubicin—muscle cancer	0.000119	0.0033	CcSEcCtD
L-Carnitine—Convulsion—Doxorubicin—muscle cancer	0.000118	0.00328	CcSEcCtD
L-Carnitine—Hypertension—Doxorubicin—muscle cancer	0.000118	0.00327	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000117	0.00325	CcSEcCtD
L-Carnitine—Insomnia—Methotrexate—muscle cancer	0.000116	0.00323	CcSEcCtD
L-Carnitine—Myalgia—Doxorubicin—muscle cancer	0.000116	0.00322	CcSEcCtD
L-Carnitine—Chest pain—Doxorubicin—muscle cancer	0.000116	0.00322	CcSEcCtD
L-Carnitine—Anxiety—Doxorubicin—muscle cancer	0.000116	0.00321	CcSEcCtD
L-Carnitine—Paraesthesia—Methotrexate—muscle cancer	0.000115	0.0032	CcSEcCtD
L-Carnitine—Dyspnoea—Methotrexate—muscle cancer	0.000115	0.00318	CcSEcCtD
L-Carnitine—Dyspepsia—Methotrexate—muscle cancer	0.000113	0.00314	CcSEcCtD
L-Carnitine—XDH—Metabolism—FH—muscle cancer	0.000112	0.00329	CbGpPWpGaD
L-Carnitine—Decreased appetite—Methotrexate—muscle cancer	0.000112	0.0031	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000111	0.00308	CcSEcCtD
L-Carnitine—Infection—Doxorubicin—muscle cancer	0.000111	0.00307	CcSEcCtD
L-Carnitine—Pain—Methotrexate—muscle cancer	0.00011	0.00305	CcSEcCtD
L-Carnitine—Tachycardia—Doxorubicin—muscle cancer	0.000109	0.00301	CcSEcCtD
L-Carnitine—Anorexia—Doxorubicin—muscle cancer	0.000106	0.00294	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000105	0.00292	CcSEcCtD
L-Carnitine—Hypotension—Doxorubicin—muscle cancer	0.000104	0.00289	CcSEcCtD
L-Carnitine—Abdominal pain—Methotrexate—muscle cancer	0.000102	0.00282	CcSEcCtD
L-Carnitine—Body temperature increased—Methotrexate—muscle cancer	0.000102	0.00282	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000101	0.00281	CcSEcCtD
L-Carnitine—Insomnia—Doxorubicin—muscle cancer	0.000101	0.00279	CcSEcCtD
L-Carnitine—Paraesthesia—Doxorubicin—muscle cancer	9.99e-05	0.00277	CcSEcCtD
L-Carnitine—Dyspnoea—Doxorubicin—muscle cancer	9.92e-05	0.00275	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	9.86e-05	0.00288	CbGpPWpGaD
L-Carnitine—Dyspepsia—Doxorubicin—muscle cancer	9.8e-05	0.00272	CcSEcCtD
L-Carnitine—Decreased appetite—Doxorubicin—muscle cancer	9.68e-05	0.00268	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Doxorubicin—muscle cancer	9.61e-05	0.00267	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—MED12—muscle cancer	9.59e-05	0.0028	CbGpPWpGaD
L-Carnitine—Pain—Doxorubicin—muscle cancer	9.52e-05	0.00264	CcSEcCtD
L-Carnitine—Constipation—Doxorubicin—muscle cancer	9.52e-05	0.00264	CcSEcCtD
L-Carnitine—Hypersensitivity—Methotrexate—muscle cancer	9.47e-05	0.00263	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—muscle cancer	9.35e-05	0.00274	CbGpPWpGaD
L-Carnitine—Asthenia—Methotrexate—muscle cancer	9.22e-05	0.00256	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Doxorubicin—muscle cancer	9.1e-05	0.00253	CcSEcCtD
L-Carnitine—Pruritus—Methotrexate—muscle cancer	9.09e-05	0.00252	CcSEcCtD
L-Carnitine—Body temperature increased—Doxorubicin—muscle cancer	8.8e-05	0.00244	CcSEcCtD
L-Carnitine—Abdominal pain—Doxorubicin—muscle cancer	8.8e-05	0.00244	CcSEcCtD
L-Carnitine—Diarrhoea—Methotrexate—muscle cancer	8.8e-05	0.00244	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—ENO2—muscle cancer	8.74e-05	0.00256	CbGpPWpGaD
L-Carnitine—Dizziness—Methotrexate—muscle cancer	8.5e-05	0.00236	CcSEcCtD
L-Carnitine—Hypersensitivity—Doxorubicin—muscle cancer	8.2e-05	0.00228	CcSEcCtD
L-Carnitine—Vomiting—Methotrexate—muscle cancer	8.17e-05	0.00227	CcSEcCtD
L-Carnitine—Rash—Methotrexate—muscle cancer	8.1e-05	0.00225	CcSEcCtD
L-Carnitine—Dermatitis—Methotrexate—muscle cancer	8.1e-05	0.00225	CcSEcCtD
L-Carnitine—Headache—Methotrexate—muscle cancer	8.05e-05	0.00223	CcSEcCtD
L-Carnitine—CROT—Metabolism—PTGS2—muscle cancer	8.01e-05	0.00234	CbGpPWpGaD
L-Carnitine—Asthenia—Doxorubicin—muscle cancer	7.99e-05	0.00222	CcSEcCtD
L-Carnitine—Pruritus—Doxorubicin—muscle cancer	7.87e-05	0.00218	CcSEcCtD
L-Carnitine—Nausea—Methotrexate—muscle cancer	7.64e-05	0.00212	CcSEcCtD
L-Carnitine—Diarrhoea—Doxorubicin—muscle cancer	7.62e-05	0.00211	CcSEcCtD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	7.5e-05	0.0022	CbGpPWpGaD
L-Carnitine—Dizziness—Doxorubicin—muscle cancer	7.36e-05	0.00204	CcSEcCtD
L-Carnitine—Vomiting—Doxorubicin—muscle cancer	7.08e-05	0.00196	CcSEcCtD
L-Carnitine—Rash—Doxorubicin—muscle cancer	7.02e-05	0.00195	CcSEcCtD
L-Carnitine—Dermatitis—Doxorubicin—muscle cancer	7.01e-05	0.00195	CcSEcCtD
L-Carnitine—Headache—Doxorubicin—muscle cancer	6.97e-05	0.00193	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.83e-05	0.002	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS2—muscle cancer	6.81e-05	0.00199	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS2—muscle cancer	6.81e-05	0.00199	CbGpPWpGaD
L-Carnitine—Nausea—Doxorubicin—muscle cancer	6.61e-05	0.00183	CcSEcCtD
L-Carnitine—XDH—Metabolism—MED12—muscle cancer	6.35e-05	0.00186	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—FH—muscle cancer	5.91e-05	0.00173	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ENO2—muscle cancer	5.79e-05	0.00169	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS2—muscle cancer	4.39e-05	0.00128	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MED12—muscle cancer	3.34e-05	0.000978	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ENO2—muscle cancer	3.05e-05	0.000891	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS2—muscle cancer	3.04e-05	0.000891	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.38e-05	0.000697	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS2—muscle cancer	2.02e-05	0.00059	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS2—muscle cancer	1.06e-05	0.00031	CbGpPWpGaD
